<DOC>
	<DOCNO>NCT03042897</DOCNO>
	<brief_summary>This pilot clinical trial study exercise diet intervention promote weight loss obese patient stage I endometrial cancer . Exercise diet may cause weight loss minimize risk gynecologic surgery related overweight patient endometrial cancer .</brief_summary>
	<brief_title>Exercise Diet Intervention Promoting Weight Loss Obese Patients With Stage I Endometrial Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine participation 16-week exercise diet intervention would elicit weight loss , assess 10 % decrease fat mass , endometrial cancer ( EC ) patient . SECONDARY OBJECTIVES : I . To determine participation 16-week exercise diet intervention would improve cardiorespiratory fitness ( CRF ) muscular strength . TERTIARY OBJECTIVES : I . To determine participation 16-week exercise diet intervention could improve quality life ( QOL ) , fatigue , depression . II . To determine effect 16-week exercise diet intervention cardiovascular ( CV ) health . OUTLINE : Patients undergo aerobic exercise thrice weekly 95 minute 16 week . Patients also undergo multi-lifestyle intervention base dietary approach stop hypertension ( DASH ) diet weekly 1 hour 16 week . After completion study , patient follow 16 week . After completion study , patient follow 16 week .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<criteria>Clinical stage I EC Low grade disease positive estrogen progesterone receptor Body mass index ( BMI ) &gt; = 30 kg/m^2 No history musculoskeletal , cardiorespiratory neurological disease preclude participation exercise Self ambulatory without use assistive walking device Is candidate immediate hysterectomy , follow evaluation physician , due desire preserve fertility , due degree obesity , due comorbidities , due patient refusal hysterectomy Must agree take progestin agent ( i.e. , oral agent MIRENA intrauterine device [ IUD ] accept treatment low grade uterine malignancy control disease intervention ongoing ) Note : potential participant WILL NOT ask delay surgery participate pilot study Patients metastatic disease BMI = &lt; 29.9 kg/m^2 History musculoskeletal , cardiorespiratory neurological disease preclude participation exercise Is self ambulatory relies use assistive walking device Is candidate immediate hysterectomy , follow evaluation physician In judgement physician , candidate progestin agent</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>